Uptake and Distribution of the Boron Containing Ether Lipid B-ET-11-OMe in Tumor Bearing Mice

A Preliminary Study
  • Peter Lemmen
  • Lothar Weißfloch
  • Thomas Auberger
  • Thomas Probst


The prospect of successful implementation of Boron Neutron Capture Therapy (BNCT) depends strongly on the availability of boron containing substances which accumulate preferentially within tumor cells. This can probably be realized by use of ether lipids.


Inductively Couple Plasma Mass Spectrometry Boron Concentration Microwave Digestion Boron Content Critical Micellar Concentration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    F. Snyder and R. Wood, Alkyl and alk-1-enyl ethers of glycerol in lipids from normal and neoplastic human tissues, Cancer Res. 29: 251–257, 1969.PubMedGoogle Scholar
  2. 2.
    B. Arnold, R. Reuther and H. U. Weltzien, Distribution and metabolism of synthetic alkyl analogs of lysophosphatidylcholine in mice, Biochim. Biophys. acta 530: 47–55, 1978.PubMedCrossRefGoogle Scholar
  3. 3.
    W. J. van-Blitterswijk, H. Hilkmann and G. A. Storme, Accumulation of an alkyl lysophospholipid in tumor cell membranes affects membrane fluidity and tumor cell invasion, Lipids 22: 820–823, 1987.PubMedCrossRefGoogle Scholar
  4. 4.
    P. Lemmen and B. Werner, Synthesis of rac-1(9-o-carboranyl)nonyl-2-methyl-glycero-3- phosphocholine (B-Et-I 1-OMe), a potential boron carrier for Boron Neutron Capture Therapy (BNCT), Chem. Phys. Lipids 62: 185–191, 1992.CrossRefGoogle Scholar
  5. 5.
    K. P. Plotzke, S. J. Fisher, R. L. Wahl, N. M. Olken, S. Skinner, M. D. Gross and R. E. Counsell, Selective localisation of a radioiodinated phospholipid ether analog in human tumor xenografts, J. Nuc. Med. 34: 787–792, 1993.Google Scholar
  6. 6.
    P. Lindström, P. Olsson, J. Malmquist, J. Pettersson, P. Lemmen, B. Werner, S. Sjöberg, Â. Olin and J. Carlsson, New carborane based compounds for boron neutron capture therapy. Binding and toxicity of ANC1, DAC1, and B-Et-11-OMe in cultured human glioma and mouse melanoma cells., Anti-Cancer Drugs 5: 43–52, 1994.PubMedCrossRefGoogle Scholar
  7. 7.
    J. Kummermehr, Measurement of tumour clonogens in situ, in: “Cell Clones: Manual of Mammalian Cell Techniques, C. S. Potten and J. H. Hendry ed., Churchill Livingstone, Edinburgh, 1985, pp. 215–222.Google Scholar
  8. 8.
    S. E. Howes, An estimation of changes in the proportion and absolute numbers of hypoxie cells after irradiation of transplanted C3H mouse mammary tumors., Br J. Radio!. 42: 441–447, 1969.CrossRefGoogle Scholar
  9. 9.
    A. A. Ferrando, N. R. Green, K. W. Barnes and B. Woodward, Microwave digestion preparation and ICP determination of boron in human plasma, Biol. Trace Element Re.s. 37: 17–25. 1993.Google Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • Peter Lemmen
    • 1
  • Lothar Weißfloch
    • 2
  • Thomas Auberger
    • 2
  • Thomas Probst
    • 3
  1. 1.Inst. f. Org. Chem. u. BiochemGermany
  2. 2.Klinikum Rechts d. IsarGermany
  3. 3.Lst. f. Radiochem.Techn. Univ. MünchenGarchingGermany

Personalised recommendations